SUBSCRIBE: Print / eNewsletter
American Radium Society Scientific Papers and Posters 2016
Proceedings of the 100th Anniversary Annual Meeting of the
(P045) Esophagus Dose Tolerance for Stereotactic Body Radiation Therapy (SBRT)
Four articles reported five deaths due to esophageal toxicity; so, our dose escalation began cautiously, and as a result, no grade ≥ 3 esophageal toxicity occurred in our series.
(P044) Comparison of Toxicity-Related Breaks in Treatment Utilizing Intensity-Modulated Radiation Therapy (IMRT) vs Three-Dimensional (3D) Conformal Techniques in the Treatment of Anal Cancer
In our small cohorts, no significant difference was seen in toxicity-related treatment breaks between IMRT and three-dimensional conformal RT.
(P043) Postoperative Bolus Electron Conformal Radiation Therapy for Soft Tissue Tumors: Initial Clinical Experience
Bolus electron conformal radiation therapy for the postoperative treatment of superficial soft tissue tumors resulted in favorable tumor control outcomes and limited radiation-related toxicity.
(P042) Development of an Integrated Microfluidic Platform for Automated Proteomic Assay Predictive of Radiation Therapy Outcomes
Such a platform technology will allow a point-of-care assay to be set up for the prediction of normal tissue toxicity after RT and ultimately for the monitoring of any intracellular protein assay diagnostic method.
(P041) Small Bowel Dose Tolerance in Stereotactic Body Radiation Therapy (SBRT) With Tumor Growth Inhibitors
Tumor growth factor inhibitors may cause more toxicity with SBRT than would otherwise be anticipated, although the absence of complications in our patients allows cautious optimism.
(P039) Dose-Dependent Change in T2 Relaxation Time Constant in Sarcoma and Normal Tissue
Our results demonstrate that there is a measurable T2 relaxation time constant change in retroperitoneal sarcoma after 28 Gy.
(P038) An MRI-Based Online Adaptive Replanning Tool
The online tool is developed to perform three different plan adaptation strategies—simple, moderate, and complex—based on the degree of the interfractional variations.
(P037) Treatment of Prognostically Favorable Peripheral Nerve Sheath Tumors: A Single-Institution Experience
Both surgery and radiation are very well tolerated treatment regimens with limited and manageable toxicity in favorable patients. Outcomes in patients with peripheral nerve sheath tumors
(P036) Causes of Mortality Among Cancer Patients
Cancer patients with the highest risk of index and nonindex cancer death and medical comorbidity death are identified; certain patient groups may be targeted with interventions.